507 related articles for article (PubMed ID: 33586060)
1. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
Srivastava A; Rathore S; Munshi A; Ramesh R
AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
[TBL] [Abstract][Full Text] [Related]
2. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
4. The role of extracellular vesicle immune checkpoints in cancer.
Zhang W; Ou M; Yang P; Ning M
Clin Exp Immunol; 2024 May; 216(3):230-239. PubMed ID: 38518192
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
Hofman P; Heeke S; Alix-Panabières C; Pantel K
Ann Oncol; 2019 Sep; 30(9):1448-1459. PubMed ID: 31228184
[TBL] [Abstract][Full Text] [Related]
6. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy.
Ayala-Mar S; Donoso-Quezada J; González-Valdez J
J Immunol Res; 2021; 2021():8839978. PubMed ID: 33628854
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises.
Bandini S; Ulivi P; Rossi T
Cells; 2024 Feb; 13(4):. PubMed ID: 38391950
[TBL] [Abstract][Full Text] [Related]
8. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.
Yan W; Jiang S
Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004
[TBL] [Abstract][Full Text] [Related]
9. Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in Oncology.
Pezzicoli G; Tucci M; Lovero D; Silvestris F; Porta C; Mannavola F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906787
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy.
Nazarenko I
Recent Results Cancer Res; 2020; 215():319-344. PubMed ID: 31605237
[TBL] [Abstract][Full Text] [Related]
11. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance.
Li I; Nabet BY
Mol Cancer; 2019 Mar; 18(1):32. PubMed ID: 30823926
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus.
Meng Q; He J; Zhong L; Zhao Y
Int J Med Sci; 2021; 18(11):2294-2302. PubMed ID: 33967605
[TBL] [Abstract][Full Text] [Related]
14. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
Ray SK; Mukherjee S
Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
[TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring.
Kamińska P; Buszka K; Zabel M; Nowicki M; Alix-Panabières C; Budna-Tukan J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575876
[TBL] [Abstract][Full Text] [Related]
16. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
[TBL] [Abstract][Full Text] [Related]
17. A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications.
Knox MC; Ni J; Bece A; Bucci J; Chin Y; Graham PH; Li Y
Front Immunol; 2020; 11():1612. PubMed ID: 32793238
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
Pi YN; Qi WC; Xia BR; Lou G; Jin WL
Front Immunol; 2021; 12():697083. PubMed ID: 34295338
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles and Their Roles in Cancer Progression.
Chang WH; Cerione RA; Antonyak MA
Methods Mol Biol; 2021; 2174():143-170. PubMed ID: 32813249
[TBL] [Abstract][Full Text] [Related]
20. The biology and clinical potential of circulating tumor cells.
Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
